AAM
TECH icon

Azzad Asset Management’s Bio-Techne TECH Stock Holding History

Azzad Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$653K Sell
12,488
-273
-2% -$16.4K 0.07% 271
2025
Q4 		$750K Sell
12,761
-1,152
-8% -$70K 0.07% 271
2025
Q3 		$774K Sell
13,913
-32,429
-70% -$1.74M 0.08% 262
2025
Q2 		$2.38M Sell
46,342
-411
-0.9% -$20.7K 0.26% 154
2025
Q1 		$2.74M Buy
46,753
+737
+2% +$49.9K 0.32% 117
2024
Q4 		$3.31M Sell
46,016
-155
-0.3% -$11.4K 0.64% 44
2024
Q3 		$3.69M Buy
46,171
+1,533
+3% +$115K 0.41% 70
2024
Q2 		$3.2M Buy
44,638
+68
+0.2% +$5K 0.38% 86
2024
Q1 		$3.14M Buy
44,570
+1,023
+2% +$73.2K 0.37% 92
2023
Q4 		$3.36M Buy
43,547
+4,787
+12% +$315K 0.43% 77
2023
Q3 		$2.64M Buy
38,760
+7,841
+25% +$619K 0.37% 90
2023
Q2 		$2.52M Buy
30,919
+3,071
+11% +$247K 0.34% 95
2023
Q1 		$2.07M Buy
27,848
+15,997
+135% +$1.23M 0.29% 129
2022
Q4 		$982K Sell
11,851
-26,225
-69% -$2.08M 0.16% 201
2022
Q3 		$2.64M Buy
38,076
+224
+0.6% +$19.4K 0.27% 132
2022
Q2 		$3.02M Buy
37,852
+13,412
+55% +$1.26M 0.3% 117
2022
Q1 		$2.65M Buy
24,440
+568
+2% +$58.6K 0.38% 85
2021
Q4 		$3.09M Sell
23,872
-1,880
-7% -$230K 0.41% 75
2021
Q3 		$3.12M Sell
25,752
-108
-0.4% -$13.1K 0.46% 59
2021
Q2 		$2.91M Sell
25,860
-2,644
-9% -$278K 0.43% 66
2021
Q1 		$2.72M Sell
28,504
-132
-0.5% -$12K 0.45% 65
2020
Q4 		$2.27M Buy
28,636
+8,100
+39% +$587K 0.41% 87
2020
Q3 		$1.27M Buy
20,536
+8,052
+64% +$524K 0.26% 142
2020
Q2 		$824K Buy
12,484
+936
+8% +$56.1K 0.19% 173
2020
Q1 		$547K Sell
11,548
-11,800
-51% -$590K 0.16% 203
2019
Q4 		$1.42M Buy
23,348
+972
+4% +$51K 0.17% 195
2019
Q3 		$1.31M Buy
22,376
+13,452
+151% +$675K 0.16% 201
2019
Q2 		$465K Sell
8,924
-148
-2% -$7.46K 0.13% 238
2019
Q1 		$450K Sell
9,072
-188
-2% -$8.46K 0.13% 234
2018
Q4 		$335K Buy
9,260
+1,316
+17% +$55K 0.11% 248
2018
Q3 		$405K Buy
+7,944
New +$352K 0.11% 265
2014
Q4 		– Sell
-13,932
Closed -$326K – 292
2014
Q3 		$326K Sell
13,932
-1,156
-8% -$27.1K 0.19% 218
2014
Q2 		$349K Sell
15,088
-6,720
-31% -$149K 0.21% 202
2014
Q1 		$465K Buy
21,808
+1,072
+5% +$24.1K 0.31% 135
2013
Q4 		$491K Sell
20,736
-16
-0.1% -$347 0.36% 117
2013
Q3 		$415K Hold
20,752
– – 0.34% 128
2013
Q2 		$415K Buy
+20,752
New +$344K 0.36% 117

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Azzad Asset Management's TECH Position: Q1 2026 in Review

Azzad Asset Management reduced its Bio-Techne (TECH) stake by 2.1% in Q1 2026, selling an estimated $16.4K and leaving 12,488 shares worth $653K. The position accounts for 0.07% of the portfolio, ranked #271.

Azzad Asset Management first reported a position in TECH in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.69M in Q3 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Azzad Asset Management held 12,488 shares of Bio-Techne worth $653K as of Q1 2026.
  • Azzad Asset Management sold 273 Bio-Techne shares in Q1 2026, an estimated $16.4K.
  • Bio-Techne made up 0.07% of Azzad Asset Management's portfolio in Q1 2026, its #271 holding.
  • Azzad Asset Management first reported a position in Bio-Techne in Q2 2013 and has held it in 37 quarters since.
  • Azzad Asset Management's Bio-Techne position peaked at $3.69M in Q3 2024.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Azzad Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.